Core Viewpoint - Weikang Pharmaceutical (300878.SZ) has received approval from the National Medical Products Administration for its drug "Er Dong Tang Granules," which enhances the company's product line and market competitiveness [1] Group 1: Product Approval - The drug "Er Dong Tang Granules" is a granule formulation with a specification equivalent to 12.44g of traditional Chinese medicine per bag [1] - The approval of this drug contributes to the diversification of the company's product offerings [1] Group 2: Market Impact - The introduction of new pharmaceutical products is subject to various factors such as industry policy changes, tender procurement, and market environment fluctuations, which may affect sales [1] - The pharmaceutical industry is characterized by high technology, high risk, and high added value, indicating potential uncertainties in product sales post-approval [1]
维康药业：获得二冬汤颗粒药品注册证书